Thibaud Haaser, S Clair, S Marty, D Berdai, H Hoarau, M C Saux, D Dreyfuss, P J Maternowski
{"title":"肿瘤学家关于治疗误解的知识、实践和伦理观点：一项法国全国调查。","authors":"Thibaud Haaser, S Clair, S Marty, D Berdai, H Hoarau, M C Saux, D Dreyfuss, P J Maternowski","doi":"10.1186/s12910-025-01260-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Therapeutic misconception (TM) among research participants refers to the conflation of research goals (generating generalisable knowledge) with clinical care goals (making the best decisions for the participants). Considering the high volume of oncology research, oncologists frequently encounter TM.</p><p><strong>Aim: </strong>To evaluate the knowledge, practices, and ethical concerns of French oncologists regarding TM.</p><p><strong>Materials and methods: </strong>A questionnaire was developed to assess oncologists' knowledge and practices concerning TM, then utilised in a national survey of French oncologists from 1 June to 14 July 2023. A descriptive statistical analysis of the responses (according to a Likert scale) was carried out.</p><p><strong>Results: </strong>In total, 288 oncologists from various specialties responded to the survey. Initial knowledge of TM was low (16%), but after the definition was provided, 84% reported having encountered TM. Respondents indicated that they paid attention to the information given during participant inclusion; however, approximately half (46%) actively investigated the presence of TM, and 22% admitted to having encouraged TM at least occasionally. Attention to TM significantly declined over the course of study protocols. Awareness of TM, along with ethics education or participation in a research ethics committee, were identified as significant factors influencing responses. The acceptability of TM was nuanced, particularly in protocols recommended to patients receiving last-line treatments. Although 64% of respondents acknowledged a link between TM and dual roles as both investigator and physician, 78% opposed transferring investigative responsibilities to a non-referent oncologist.</p><p><strong>Conclusion: </strong>TM is a widespread but still mostly unknown phenomenon which could easily be tackled for better outcomes for patients. This study revealed considerable variability in knowledge, practices, and ethical considerations related to TM among French oncologists. Enhanced education and ethical support are needed to improve awareness and foster appropriate behaviours concerning TM.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":55348,"journal":{"name":"BMC Medical Ethics","volume":"26 1","pages":"94"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12247256/pdf/","citationCount":"0","resultStr":"{\"title\":\"Oncologists' knowledge, practices and ethical opinions about therapeutic misconception: a French national survey.\",\"authors\":\"Thibaud Haaser, S Clair, S Marty, D Berdai, H Hoarau, M C Saux, D Dreyfuss, P J Maternowski\",\"doi\":\"10.1186/s12910-025-01260-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Therapeutic misconception (TM) among research participants refers to the conflation of research goals (generating generalisable knowledge) with clinical care goals (making the best decisions for the participants). Considering the high volume of oncology research, oncologists frequently encounter TM.</p><p><strong>Aim: </strong>To evaluate the knowledge, practices, and ethical concerns of French oncologists regarding TM.</p><p><strong>Materials and methods: </strong>A questionnaire was developed to assess oncologists' knowledge and practices concerning TM, then utilised in a national survey of French oncologists from 1 June to 14 July 2023. A descriptive statistical analysis of the responses (according to a Likert scale) was carried out.</p><p><strong>Results: </strong>In total, 288 oncologists from various specialties responded to the survey. Initial knowledge of TM was low (16%), but after the definition was provided, 84% reported having encountered TM. Respondents indicated that they paid attention to the information given during participant inclusion; however, approximately half (46%) actively investigated the presence of TM, and 22% admitted to having encouraged TM at least occasionally. Attention to TM significantly declined over the course of study protocols. Awareness of TM, along with ethics education or participation in a research ethics committee, were identified as significant factors influencing responses. The acceptability of TM was nuanced, particularly in protocols recommended to patients receiving last-line treatments. Although 64% of respondents acknowledged a link between TM and dual roles as both investigator and physician, 78% opposed transferring investigative responsibilities to a non-referent oncologist.</p><p><strong>Conclusion: </strong>TM is a widespread but still mostly unknown phenomenon which could easily be tackled for better outcomes for patients. This study revealed considerable variability in knowledge, practices, and ethical considerations related to TM among French oncologists. Enhanced education and ethical support are needed to improve awareness and foster appropriate behaviours concerning TM.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>\",\"PeriodicalId\":55348,\"journal\":{\"name\":\"BMC Medical Ethics\",\"volume\":\"26 1\",\"pages\":\"94\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12247256/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Medical Ethics\",\"FirstCategoryId\":\"98\",\"ListUrlMain\":\"https://doi.org/10.1186/s12910-025-01260-y\",\"RegionNum\":1,\"RegionCategory\":\"哲学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ETHICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Ethics","FirstCategoryId":"98","ListUrlMain":"https://doi.org/10.1186/s12910-025-01260-y","RegionNum":1,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ETHICS","Score":null,"Total":0}
Oncologists' knowledge, practices and ethical opinions about therapeutic misconception: a French national survey.
Background: Therapeutic misconception (TM) among research participants refers to the conflation of research goals (generating generalisable knowledge) with clinical care goals (making the best decisions for the participants). Considering the high volume of oncology research, oncologists frequently encounter TM.
Aim: To evaluate the knowledge, practices, and ethical concerns of French oncologists regarding TM.
Materials and methods: A questionnaire was developed to assess oncologists' knowledge and practices concerning TM, then utilised in a national survey of French oncologists from 1 June to 14 July 2023. A descriptive statistical analysis of the responses (according to a Likert scale) was carried out.
Results: In total, 288 oncologists from various specialties responded to the survey. Initial knowledge of TM was low (16%), but after the definition was provided, 84% reported having encountered TM. Respondents indicated that they paid attention to the information given during participant inclusion; however, approximately half (46%) actively investigated the presence of TM, and 22% admitted to having encouraged TM at least occasionally. Attention to TM significantly declined over the course of study protocols. Awareness of TM, along with ethics education or participation in a research ethics committee, were identified as significant factors influencing responses. The acceptability of TM was nuanced, particularly in protocols recommended to patients receiving last-line treatments. Although 64% of respondents acknowledged a link between TM and dual roles as both investigator and physician, 78% opposed transferring investigative responsibilities to a non-referent oncologist.
Conclusion: TM is a widespread but still mostly unknown phenomenon which could easily be tackled for better outcomes for patients. This study revealed considerable variability in knowledge, practices, and ethical considerations related to TM among French oncologists. Enhanced education and ethical support are needed to improve awareness and foster appropriate behaviours concerning TM.
期刊介绍：
BMC Medical Ethics is an open access journal publishing original peer-reviewed research articles in relation to the ethical aspects of biomedical research and clinical practice, including professional choices and conduct, medical technologies, healthcare systems and health policies.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
